on the basis of this observation , a double-blind , placebo-controlled study in patients with early parkinson 's disease was initiated to determine whether deprenyl ( a selective monoamine oxidase b inhibitor ) would delay the need for l-dopa therapy by slowing the progression of the disease .
C0030567
parkinson 's disease
C0023570
l-dopa